Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia

@article{Fink2018PharmacologicIT,
  title={Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia},
  author={H. Fink and E. Jutkowitz and J. McCarten and L. Hemmy and M. Butler and H. Davila and E. Ratner and Collin Calvert and T. Barclay and M. Brasure and Victoria A. Nelson and R. Kane},
  journal={Annals of Internal Medicine},
  year={2018},
  volume={168},
  pages={39-51}
}
  • H. Fink, E. Jutkowitz, +9 authors R. Kane
  • Published 2018
  • Medicine
  • Annals of Internal Medicine
  • Dementia is a clinical syndrome in which an acquired cognitive deficit interferes with a person's independence in daily activities (1). It adversely affects patient quality of life, burdens caregivers, increases institutionalization, and is costly to families and society (2). Alzheimer disease is the most common cause of dementia, although differentiation between when Alzheimer disease is present in isolation and when it is combined with another cause of dementia may not be possible in clinical… CONTINUE READING
    Mild Cognitive Impairment in Clinical Practice: A Review Article
    • 10
    • Highly Influenced
    Nutritional prevention of cognitive decline and dementia
    • 11
    • Highly Influenced
    Prevention of Late-Life Dementia: No Magic Bullet
    • 9
    • PDF
    Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies
    • 10
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 135 REFERENCES
    Mild cognitive impairment as a diagnostic entity
    • 4,975
    Vitamin E and donepezil for the treatment of mild cognitive impairment.
    • 1,530
    • PDF